Tramadol for premature ejaculation: a systematic review and meta-analysis
- PMID: 25636495
- PMCID: PMC4417346
- DOI: 10.1186/1471-2490-15-6
Tramadol for premature ejaculation: a systematic review and meta-analysis
Abstract
Background: Tramadol is a centrally acting analgesic prescribed off-label for the treatment of premature ejaculation (PE). However, tramadol may cause addiction and difficulty in breathing and the beneficial effect of tramadol in PE is yet not supported by a high level of evidence. The purpose of this study was to systematically review the evidence from randomised controlled trials (RCT) for tramadol in the management of PE.
Methods: We searched bibliographic databases including MEDLINE to August 2014 for RCTs. The primary outcome was intra-vaginal ejaculatory latency time (IELT). Methodological quality of RCTs was assessed. Between-group differences in IELT and other outcomes were pooled across RCTs in a meta-analysis. Statistical and clinical between-trial heterogeneity was assessed.
Results: A total of eight RCTs that evaluated tramadol against a comparator were included. The majority of RCTs were of unclear methodological quality due to limited reporting. Pooled evidence (four RCTs, 721 participants), suggests that tramadol is significantly more effective than placebo at increasing IELT over eight to 12 weeks (p = 0.0007). However, a high level of statistical heterogeneity is evident (I-squared = 74%). Single RCT evidence indicates that tramadol is significantly more effective than paroxetine taken on-demand, sildenafil, lidocaine gel, or behavioural therapy on IELT in men with PE. Tramadol is associated with significantly more adverse events including: erectile dysfunction, constipation, nausea, headache, somnolence, dry mouth, dizziness, pruritus, and vomiting, than placebo or behavioural therapy over eight to 12 weeks of treatment. However, addiction problems or breathing difficulties reported by patients for PE is not assessed in the current evidence base.
Conclusions: Tramadol appears effective in the treatment of PE. However, these findings should be interpreted with caution given the observed levels of between-trial heterogeneity and the reporting quality of the available evidence. The variability across placebo-controlled trials in terms of the tramadol dose evaluated and the treatment duration does not permit any assessment of a safe and effective minimum daily dose. The long-term effects and side effects, including addiction potential, for men with PE have not been evaluated in the current evidence base.
Trial registration: The review is registered on PROSPERO 2013: CRD42013005289 .
Figures
Similar articles
-
Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis.Eur Urol Focus. 2017 Feb;3(1):119-129. doi: 10.1016/j.euf.2016.02.001. Epub 2016 Feb 19. Eur Urol Focus. 2017. PMID: 28720356 Free PMC article.
-
Topical anaesthetics for premature ejaculation: a systematic review and meta-analysis.Sex Health. 2016 Apr;13(2):114-23. doi: 10.1071/SH15042. Sex Health. 2016. PMID: 26599522 Review.
-
Interventions to treat premature ejaculation: a systematic review short report.Health Technol Assess. 2015 Mar;19(21):1-180, v-vi. doi: 10.3310/hta19210. Health Technol Assess. 2015. PMID: 25768099 Free PMC article. Review.
-
Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis.BMC Urol. 2019 Jan 3;19(1):2. doi: 10.1186/s12894-018-0431-7. BMC Urol. 2019. PMID: 30606186 Free PMC article.
-
Role of tramadol in premature ejaculation: a systematic review and meta-analysis.Urol Int. 2013;91(2):197-205. doi: 10.1159/000348826. Epub 2013 Jun 6. Urol Int. 2013. PMID: 23751284 Review.
Cited by
-
Combined on-demand sildenafil citrate and tramadol hydrochloride is an effective and safe treatment for premature ejaculation: A randomized placebo-controlled double-blind clinical trial.Arab J Urol. 2023 Nov 30;22(2):89-95. doi: 10.1080/20905998.2023.2287869. eCollection 2024. Arab J Urol. 2023. PMID: 38481408 Free PMC article.
-
Tramadol poisoning and its management and complications: a scoping review.Ann Med Surg (Lond). 2023 Jul 7;85(8):3982-3989. doi: 10.1097/MS9.0000000000001075. eCollection 2023 Aug. Ann Med Surg (Lond). 2023. PMID: 37554850 Free PMC article.
-
Tramadol-induced intracerebral hemorrhage: A rare case report.Clin Case Rep. 2023 Apr 12;11(4):e7205. doi: 10.1002/ccr3.7205. eCollection 2023 Apr. Clin Case Rep. 2023. PMID: 37064737 Free PMC article.
-
The Men's Training Cup Keep Training: a masturbation aid improves intravaginal ejaculatory latency time and Erection Hardness Score in patients who are unable to delay ejaculation.Sex Med. 2023 Jan 18;11(1):qfac010. doi: 10.1093/sexmed/qfac010. eCollection 2023 Feb. Sex Med. 2023. PMID: 37007846 Free PMC article.
-
Investigating the Impact of Kratom (Mitragyna speciosa) Use Upon Male Sexual Health.Res Rep Urol. 2023 Feb 10;15:69-76. doi: 10.2147/RRU.S390094. eCollection 2023. Res Rep Urol. 2023. PMID: 36798621 Free PMC article.
References
-
- McMahon CG, Althof S, Waldinger MD, Porst H, Dean J, Sharlip I, et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. BJU Int. 2008;102:338–50. doi: 10.1111/j.1464-410X.2008.07755.x. - DOI - PubMed
-
- U.S.Food and Drug Administration: Warning letter to William Weldon, CEO & Chairman of Johnson & Johnson, regarding Ultram-ER web advertisement. 19–5-2009. [Accessed 10–7-2014] http://www.fda.gov/downloads/Drugs/.../UCM153130.pdf
Pre-publication history
-
- The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2490/15/6/prepub
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources